Research and Development

Buderer Drug performs research and development for pharmaceutical companies to develop new drugs for FDA approval and preparation for Phase 1 and Phase 2 clinical trials.

Matt is the Director of Research and Development for Buderer Drug Company. He has published articles in peer-reviewed journals with his biostatistician wife, Nancy. To date, he is co-inventor on 6 different drug patent submissions with 2 executed patents pending. Matt has provided dosage form development and formulations for the biotech and OTC drug industry. Buderer Drug has prepared medications for drug companies for FDA Phase 1 and Phase 2 clinical trials.